Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
GILD AMGN BIIB CELG Beers Books Commodities Drugs 
United States  USA  |  Investing Themes


Processing
Processing. Please wait...

BioTime One Year High

 
 Companies |  Insiders  | Dashboard  
     

One Year High breakdown for BioTime

One Year High typically refers to the highest price that a given equity instrument has reached in the last 52 weeks. In other words it is the highest price that investors paid or were willing to pay for a given stock, fund, or ETF over the past 52 weeks of trading.

BioTime

One Year High

=

Highest Price in the Last 52 Weeks

=
5.07
Year High value is used as an indicator to give investors an idea of how a given equity may perform over mid or longer term horizons. The One Year High may be utilized as a naive indicator of how the value of stock is resistant or elastic over the long term investment horizon. For example if the price of a fund or ETF is near a new One Year High, a rational investor may interpret it as a turning point and trade the instrument away or buy additional shares.
Compare BioTime to competition

BioTime One Year High Assessment

Based on recorded statements BioTime Inc has One Year High of 5.07. This is 87.59% lower than that of Healthcare sector, and 79.21% lower than that of Biotechnology industry, The One Year High for all stocks is 86.13% higher than the company.

Filter other Stocks by One Year High

Select One Year High Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  

One Year High Comparison

BioTime is currently under evaluation in one year high category among related companies.
Follow BioTime One Year High with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add BioTime to your reader
 
    
BTX United States AMEX
BioTime Inc
Currency: USD - US Dollar
Traded on American Stock Exchange
    
    

Other BioTime Fundamentals

Return On Equity(83.51) %
Return On Asset(46.22) %
Operating Margin(708) %
Current Valuation204.52 M
Shares Outstanding49.38 M
Shares Owned by Insiders47.78 %
Shares Owned by Institutions13.00 %
Number of Shares Shorted6.84 M
Price to Book19.95 times
Price to Sales48.81 times
Revenue3.88 M
Gross Profit3.48 M
EBITDA(24.55 M)
Net Income(24.17 M)
Cash and Equivalents9.9 M
Cash per Share0.19 times
Current Ratio3.02 times
Book Value Per Share0.19 times
Cash Flow from Operations(19.68 M)
Short Ratio47.20 times
One Year High5.07
One Year Low2.67
Earnings Per Share(0.49) times
Number of Employees73
Beta1.06
Market Capitalization201.48 M
Total Asset29.75 M
Retained Earnings(101.9 M)
Working Capital2.79 M
Current Asset7.18 M
Current Liabilities4.39 M
Z Score-4.2
Probability Of Bankruptcy88.20 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium